Clinical performance of a new prediction rule of systemic loxoscellism. case report

REPORTE DE CASO

REVISTA DE LA FACULTAD DE MEDICINA HUMANA 2021 - Universidad Ricardo Palma
10.25176/RFMH.v21i4.3956

CLINICAL PERFORMANCE OF A NEW PREDICTION RULE OF SYSTEMIC LOXOSCELLISM. CASE REPORT

RENDIMIENTO CLINICO DE UNA NUEVA REGLA DE PREDICCION DEL LOXOSCELISMO SISTÉMICO. REPORTE DE CASO

Rafael Pichardo-Rodriguez 1, 2; Marcos Saavedra-Velasco2; Cesar Sánchez-Alvarez3; Juan-Jesús Bracamonte-Hernández4; Abel Aldave-Visurraga5; Oscar Ruiz-Franco6

1. Instituto de Investigaciones en Ciencias Biomédicas (INICIB). Universidad Ricardo Palma, Lima-Perú.
2. Centro especializado de enfermedades infecciosas, Lima, Perú.
3. Servicio de Enfermedades Infecciosas y Tropicales, Hospital Nacional “Dos De Mayo”-MINSA, Lima, Perú.
4. Human Medicine student at Ricardo Palma University.
5. Servicio de Emergencia y Desastres, Hospital Nacional “Dos De Mayo”-MINSA, Lima, Perú.
6. Servicio de Hematología, Hospital Nacional “Dos De Mayo”-MINSA, Lima, Perú.

ABSTRACT

Systemic or cutaneous-visceral loxoscelism is the most severe clinical presentation of loxoscelism. Currently there is no validated laboratory diagnostic method that allows us to confirm the presence of this disease in the face of arachneism. However, there is a clinical prediction rule (CPR), which allows us to predict the evolution of a bite towards a systemic condition and which would be useful in emergency rooms. We present the case of a woman who developed the systemic picture of loxoscelism to whom a new CPR was applied for the early detection of systemic loxoscelism, presenting adequate performance for early evaluation in emergency services.

Keywords: Spider Bite, Hemolysis, Clinical Decision Rules (Source: MeSH NLM).

RESUMEN

El loxoscelismo sistémico o cutáneo-visceral, es la presentación clínica más severa del loxoscelismo. Actualmente no se cuenta con algún método diagnóstico laboratorial validado que nos permita confirmar la presencia de esta enfermedad frente a un aracneismo. Sin embargo, existe una regla de predicción clínica (RPC), que nos permite predecir la evolución de una picadura hacia un cuadro sistémico y que sería de utilidad en las salas de emergencia. Presentamos el caso de una mujer que desarrollo el cuadro sistémico del loxoscelismo a la que se le aplicó una nueva RPC para la detección temprana del loxoscelismo sistémico, presentando un rendimiento adecuado para la evaluación temprana en los servicios de emergencia.

Palabras Clave: Venenos de Araña, Hemólisis, Reglas de Decisión Clínica (Fuente: DeCS BIREME).

CASE REPORT

Systemic or cutaneous-visceral loxoscelism is the most severe clinical presentation of loxoscelism(1). This is generated after a spider bite of the genus Loxosceles. The pathophysiology is still unknown and is probably associated with a direct action of the venom on tissues, mainly erythrocytes, causing complement-mediated intravascular hemolysis and probably immunoglobulins, ultimately leading to acute renal failure and death (2,3). Treatment is based on the early application (within 12 hours) of antivenom (anti-loxoscelic serum) and support measures (hydration, antibiotic therapy, corticosteroid therapy, antihistamines, among others). (1).

Currently there is no validated laboratory diagnostic method that allows us to confirm the presence of this disease in the presence of arachneism. Nevertheless, there is a clinical prediction rule (CPR), which would allow us to predict the evolution of a bite towards a systemic condition, with the drawback that it still requires external validation (4). Despite this, it represents an important resource for emergency services, where it is necessary to make quick decisions for the treatment of pathologies that may compromise the patient's life.

We present the case of a woman who developed the systemic picture of loxoscelism to whom a new CPR was applied for the early detection of systemic loxoscelism, presenting adequate performance for early evaluation in emergency services

CASE PRESENTATION

Past medical history and clinical presentation

A 21-year-old woman, with no significant medical history, went to the emergency service due to jaundice and a violaceous lesion associated with paresthesia at the level of the right iliac fossa (RIF). She refers two days before the admission, while dressing, feels a bite at the RIF level, seeing a spider fall and escaped through the clothes. After this, she presented fever (38.5 ° C), hemoglobinuria, jaundice and violation of the sting area, associated with decreased urinary volume.

CLINICAL EXAM

Examination revealed jaundice of the skin and mucosa and a violaceous lesion at the RIF level of approximately 7x4 cm with increased volume and heat, painful on palpation (see Figure 1).

Figure 1: 7x4 cm violaceous lesion at RIF level associated with increased temperature, pain on palpation and increased volume.


LABORATORY RESULTS

The diagnosis of systemic loxoscelism associated with cellulitis is proposed and the pertinent laboratory tests and consultation with the infectology service are requested. The results are presented in table 1

Tabla 1. Laboratory test results

  Admition Second day in emergency
Hemoglobin (g/dL) 14,2 12,9
Lymphocytes (Lymphocytes /mm3) 850 850
Indirect bilirubin (mg/dL) 4,02 3,2
Urea (mg/dL) 0,60 0,40
Creatinine (mg/dL) 31,52 26,54
Rapid test for COVID-19 (IgG e IgM)* Non reactive  
* COVID-19: Disease due to the new coronavirus 2019.


Spiders of the genus Loxosceles photos are presented to the patient, who recognizes its as responsible for the accident. The CPR elaborated by Pichardo-Rodriguez et al is applied, obtaining a score of 7, confirming the presence of a systemic condition with a specificity of 93.8%. table 2 shows the CPR for the prediction of systemic loxoscelism.

Table 2. Clinical prediction rule for predicting systemic loxoscelism.

Variables Score
Male gender 2
Threw up 2
Fever 3
Hemoglobinuria 4


A score of ≥4 would indicate, with a sensitivity of 79.1% and a specificity of 93.8%, the presence of systemic loxoscelism.Source: R. Pichardo-Rodriguez, M. Saavedra-Velasco, J. Ascarza-Saldaña, C. Naquira-Velarde, Development and validation of a clinical prediction rule to identify systemic compromise in cases of loxoscelism, Mag. Fac. Med. Humana. 20 (2020) 1–1. https://doi.org/10.25176/RFMH.v20i1.2642.

Therapeutic interventions

It was decided to start antiloxoscelic serum (1 ampoule in 100ml of physiological saline), showing no adverse reactions to antivenom. Energetic hydration and antibiotic therapy are established (intravenous Oxacillin 2g every 6 hours).

Follow-up and result

The patient evolves favorably, recovering normal urinary volume. Infectology confirms the presence of a systemic Loxoscelism and her hospitalization is decided to continue the medical management.

DISCUSSION

The systemic picture of loxoscelism in our patient was adequately predicted using the CPR elaborated by Pichardo-Rodriguez et al. The main limitation of this clinical tool is the absence of external validation, however, in our case, it demonstrated adequate clinical performance to detect the event in emergency department. The CPR is conformed by four variables: Male gender, vomiting, fever and hemoglobinuria, with a respective score of 2, 2, 3 and 4 for each one (4). The cut-off point for the score is 4, which predicts a sensitivity of 79.1% and a specificity of 93.8% for the presence of a systemic picture of loxoscelism (4). Our patient had a score of 7, confirming the presence of the disease. It is important to carry out prospective studies to validate this tool in our population and evaluate its predictive capacity in emergency services or primary care, as well as the inclusion of new predictors that allow us to improve its performance.

Systemic loxoscelism, unlike in our case, is more frequent in men. The association of the systemic condition with the spider bite has been reported in the chest and abdomen, and this association was found in our patient (5). The exact pathophysiology of the disease is still unknown, but a direct action of sphingomyelinase D toxin on the surface of erythrocytes is postulated with a direct complement interaction, the presence of erythrocytes covered with C3 as well as those covered with antibodies has been reported. , sphingomyelinate D is probably a trigger for this alteration (2,3). Paresthesias such as those presented by our patient are part of the neurological compromise of loxoscelism, it has been found that some components of the venom have direct action on the nervous system, causing symptoms such as paresthesia and in animals causing damage to the choroid plexus and area postmas (6, 7). However, it has not been associated with seizures.

Jaundice of the skin and mucosa associated with hemoglobinuria were clinical signs of the presence of intravascular hemolysis, probably associated with renal tamponade that improved with hydration, however, renal function tests remained within normal ranges (1). Intravascular hemolysis is the most important alteration of systemic loxoscelism that subsequently leads to tamponade and acute renal failure (1,3,4). Therefore, it is relevant to start and continue with vigorous hydration in order to avoid kidney damage, taking special care in those who cannot handle high intravascular volumes (heart failure, liver cirrhosis, chronic kidney disease, among others) (1). Cellulitis is a frequent finding in loxoscelism which was found associated in our patient (3).

Lymphopenia was a finding in our patient and its cause in loxoscelism is not fully understood, however, it has been reported in pediatric patients (8). In a study where Loxosceles Apachea venom was applied experimentally at different doses in rats, it was possible to observe leukopenia, lymphopenia, neutrophilia and acantocytosis in peripheral blood (7). Loxosceles venom appears to be directly toxic to blood cells.

In relation to treatment, the specific intervention for loxoscelism is the application of antivenom (4). There is still no evidence based on clinical trials or large prospective cohorts that allow us to evaluate the safety and efficacy of this treatment, but early application is recommended, if possible before 12 hours after the event occurred. There is still no evidence based on clinical trials or large prospective cohorts that allow us to evaluate the safety and efficacy of this treatment, but early application is recommended, if possible, less than 12 hours after the event occurred. It is recommended to dilute a 5ml ampoule in a bottle in 100ml of physiological saline in adults (1). There are no reports of adverse effects or anaphylaxis to antivenom, and based on our experience, we have not observed adverse or anaphylactic reactions.

CONCLUSION

In conclusion, CPR present an adequate clinical performance predicting the systemic symptoms in patients with loxoscelism treated in emergency departments. External validation of this clinical tool is required, as well as prospective studies on systemic loxoscelism.


Authorship: The authors RPR, MSV, AAV participated in the study conception, collection, analysis and data discussion. RPR, MSV, AAV, CSA and ORF participated in the manuscript preparation, bibliographic search and approval of the final version of the manuscript.
Financing: Self-financed
Declaration of conflicts of interest: No conflicts of interest are declared
received: June 04, 2021
Approved: July 11, 2021


Correspondence: Juan-Jesús Bracamonte-Hernández
Address: Calle Julio Mini Rivas 281 Urb. San Amadeo de Garagay, San Martin de Porres, Lima.
Cellphone: 997473135
Email: juanjesus.bracamonte@gmail.com


REFERENCES

    1 C. Maguiña Vargas, V. Figueroa Vásquez, R. Pulcha Ugarte, Actualización sobre manejo de araneismo en Perú, Rev. Medica Hered. 28 (2017) 200–207. https://doi.org/10.20453/rmh.v28i3.3189.
    2 J. McDade, B. Aygun, R.E. Ware, Brown recluse spider (Loxosceles reclusa) envenomation leading to acute hemolytic anemia in six adolescents, J. Pediatr. 156 (2010) 155–157. https://doi.org/10.1016/j.jpeds.2009.07.021.
    3 N. Nguyen, M. Pandey, Loxoscelism: Cutaneous and Hematologic Manifestations, Adv. Hematol. 2019 (2019). https://doi.org/10.1155/2019/4091278.
    4 R. Pichardo-Rodriguez, M. Saavedra-Velasco, J. Ascarza-Saldaña, C. Naquira-Velarde, Elaboración y validación de una regla de predicción clinica para identificar compromiso sistemico en casos de loxoscelismo, Rev. Fac. Med. Humana. 20 (2020) 1–1. https://doi.org/10.25176/RFMH.v20i1.2642.
    5 C.M. Webb Camminati, C. Maguiña Vargas, E. González Lagos, Factores asociados a la presentación víscero-hemolítica de loxoscelismo en el Hospital Nacional Cayetano Heredia, entre el 2000 y 2008, Acta Médica Peru. 27 (2010) 29–36.
    6 R. Pichardo-Rodriguez, J.A. Grandez-Urbina, S. Zegarra del Rosario-Alvarado, V.A. del Carpio-Yañez, M. Saavedra-Velasco, H.A. Garcia-Perdomo, Loxoscelismo sistémico en un paciente epiléptico. Reporte de caso, Rev. Científica Soc. Esp. Enferm. Neurológica. (2020) S2013524619300273. https://doi.org/10.1016/j.sedene.2019.10.004.
    7 L.F. Plenge-Tellechea, Á.D. Hernández-Ramos, J.M. Muñoz, G. Barraza-Garza, E. Rico-Escobar, D. Meléndez-Martínez, Acanthocytosis and brain damage in area postrema and choroid plexus: Description of novel signs of Loxosceles apachea envenomation in rats, PLOS ONE. 14 (2019) e0211689. https://doi.org/10.1371/journal.pone.0211689.
    8 Norberto Gómez-Rivera, María Guadalupe García-Zárate, Luis Villalobos-García, Elba Vázquez-Pizaña, Ignacio Fonseca-Chon, Loxoscelismo Cutáneo y Loxoscelismo Sistémico en Pediatría: Presentación de 2 Casos Clínicos y Tratamiento., Bol Clin Hosp Infant Edo Son. 31 (2014) 46–50.

http://www.scielo.org.pe/scielo.php?script=sci_serial&pid=2223-2516&lng=en&nrm=iso


¿Quieres dejar tu comentario o sugerencia sobre este artículo?

---> CLICK AQUI <---